Publikationen in Zusammenarbeit mit Forschern von University Hospital Heidelberg (5)

2023

  1. Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory BRAF V600 Mutant Pediatric High-Grade Glioma

    Journal of Clinical Oncology, Vol. 41, Núm. 33, pp. 5174-5183

2017

  1. Pediatric low-grade gliomas: Implications of the biologic era

    Neuro-Oncology, Vol. 19, Núm. 6, pp. 750-761

2016

  1. No correlation between NF1 mutation position and risk of optic pathway glioma in 77 unrelated NF1 patients

    Human Genetics, Vol. 135, Núm. 5, pp. 469-475

  2. Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis

    The Lancet Oncology, Vol. 17, Núm. 4, pp. 484-495

  3. Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: A retrospective multicohort analysis

    Journal of Clinical Oncology, Vol. 34, Núm. 21, pp. 2468-2477